<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37794442</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1477-7827</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Reproductive biology and endocrinology : RB&amp;E</Title><ISOAbbreviation>Reprod Biol Endocrinol</ISOAbbreviation></Journal><ArticleTitle>Metabolic/endocrine disorders in survivors of childhood-onset and cranial radiotherapy- treated ALL/NHL: a meta-analysis.</ArticleTitle><Pagination><StartPage>91</StartPage><MedlinePgn>91</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">91</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12958-023-01137-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cranial radiotherapy (CRT) is recommended to high-risk pediatric patients with acute lymphoblastic leukemia or aggressive non-Hodgkin's lymphoma (ALL/NHL). However, effects of CRT treatment on the development of metabolic/endocrine disorders remain unclear. This meta-analysis aimed to identify metabolic and endocrine disturbances in survivors of childhood-onset and CRT-treated ALL/NHL.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Different online databases were searched using restricted search fields. Follow-up data and outcome measurements, including the prevalence of growth hormone (GH) deficiency, hypothyroidism, vitamin D deficiency, overweight/obesity, and hypogonadism were recorded. The height data was indicated by height-standard deviation score (height-SDS). Statistical estimates such as odds ratio (OR) and weighted standard mean difference (SMD) were compared between additional CRT treatment group and non-CRT treatment group. Study-to-study heterogeneity was calculated by calculating I-squared statistic, and fixed/random effect was applied to synthesize and analyze extracted data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifteen studies were included (4269 patients in total). Adult height SDS was lower in CRT-treated patients (pooled SMD = -0.581, 95% CI: -0.649--0.512), and CRT-treated patients were likely to develop short stature (pooled OR&#x2009;=&#x2009;2.289, 95% CI:1.674-3.130). Regardless of the study year, which potentially reflects the state-of-the-art CRT technique, the prevalence of short stature and GH deficiency was time-independent. Additionally, previous CRT can increase the risk of precocious puberty (pooled OR&#x2009;=&#x2009;2.937, 95% CI: 1.281-6.736), hypothyroidism (pooled OR&#x2009;=&#x2009;2.057, 95% CI:1.510-2.801), and hypogonadism (pooled OR&#x2009;=&#x2009;3.098, 95% CI:2.521-3.807). However, the risk of being overweight/obese was similar between the patients with and without CRT (pooled OR&#x2009;=&#x2009;1.278, 95% CI: 0.675-2.421).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Childhood-onset and CRT-treated ALL/NHL survivors are likely to have shorter height, precocious puberty, hypothyroidism, and hypogonadism.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatric Endocrine and Metabolism, Shengjing Hospital of China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Shengjing Hospital of China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, China. malangumin@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Reprod Biol Endocrinol</MedlineTA><NlmUniqueID>101153627</NlmUniqueID><ISSNLinking>1477-7827</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011629" MajorTopicYN="Y">Puberty, Precocious</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050177" MajorTopicYN="N">Overweight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004700" MajorTopicYN="Y">Endocrine System Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008659" MajorTopicYN="Y">Metabolic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007037" MajorTopicYN="Y">Hypothyroidism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007006" MajorTopicYN="Y">Hypogonadism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute lymphoblastic leukemia</Keyword><Keyword MajorTopicYN="N">Cranial radiotherapy</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Non-hodgkin&#x2019;s lymphoma</Keyword><Keyword MajorTopicYN="N">metabolic/endocrine disorders</Keyword></KeywordList><CoiStatement>All the authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>1</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>23</Hour><Minute>45</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37794442</ArticleId><ArticleId IdType="pmc">PMC10548660</ArticleId><ArticleId IdType="doi">10.1186/s12958-023-01137-y</ArticleId><ArticleId IdType="pii">10.1186/s12958-023-01137-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Howard SC, Pui CH. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Rev. 2002;16(4):225&#x2013;43. doi: 10.1016/S0268-960X(02)00042-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0268-960X(02)00042-5</ArticleId><ArticleId IdType="pubmed">12350366</ArticleId></ArticleIdList></Reference><Reference><Citation>Moritani K, Tauchi H, Ochi F, Yonezawa S, Takemoto K, Eguchi-Ishimae M, et al. Prolonged adrenal insufficiency after high-dose glucocorticoid in infants with leukemia. Pediatr Hematol Oncol. 2018;35(5&#x2013;6):355&#x2013;61. doi: 10.1080/08880018.2018.1539148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08880018.2018.1539148</ArticleId><ArticleId IdType="pubmed">30457427</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. Am Fam Physician. 2014;89(9):731&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24784336</ArticleId></ArticleIdList></Reference><Reference><Citation>Dandoy CE, Davies SM, Woo Ahn K, He Y, Kolb AE, Levine J, et al. Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children. Haematologica. 2021;106(7):1839&#x2013;45. doi: 10.3324/haematol.2020.249458.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2020.249458</ArticleId><ArticleId IdType="pmc">PMC8252927</ArticleId><ArticleId IdType="pubmed">32554562</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahnukainen K, Heikkinen R, Henriksson M, Cooper TG, Puukko-Viertomies LR, M&#xe4;kitie O. Semen quality and fertility in adult long-term survivors of childhood acute lymphoblastic leukemia. Fertil Steril. 2011;96(4):837&#x2013;42. doi: 10.1016/j.fertnstert.2011.07.1147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2011.07.1147</ArticleId><ArticleId IdType="pubmed">21868007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly MJ, Trikalinos TA, Dahabreh IJ, Gianferante M, Parsons SK. Cranial radiation for pediatric T-lineage acute lymphoblastic leukemia: a systematic review and meta-analysis. Am J Hematol. 2014;89(10):992&#x2013;7. doi: 10.1002/ajh.23784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.23784</ArticleId><ArticleId IdType="pmc">PMC4167220</ArticleId><ArticleId IdType="pubmed">24912665</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathyapalan T, Dixit S. Radiotherapy-induced hypopituitarism: a review. Expert Rev Anticancer Ther. 2012;12(5):669&#x2013;83. doi: 10.1586/era.12.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/era.12.27</ArticleId><ArticleId IdType="pubmed">22594901</ArticleId></ArticleIdList></Reference><Reference><Citation>Follin C, Erfurth EM. Long-term effect of Cranial Radiotherapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors. Curr Treat Options Oncol. 2016;17(9):50. doi: 10.1007/s11864-016-0426-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11864-016-0426-0</ArticleId><ArticleId IdType="pmc">PMC4967419</ArticleId><ArticleId IdType="pubmed">27476159</ArticleId></ArticleIdList></Reference><Reference><Citation>Lekovic GP, Batra A, Barnard ZR, Wilkinson EP, Balena R, Palejwala S, et al. Growth hormone-secreting pituitary macroadenoma presenting concurrently with non-hodgkin&#x2019;s lymphoma and responding to doxorubicin treatment: case report and review of the literature. Acta Neurochir (Wien) 2018;160(12):2363&#x2013;6. doi: 10.1007/s00701-018-3714-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-018-3714-6</ArticleId><ArticleId IdType="pubmed">30370442</ArticleId></ArticleIdList></Reference><Reference><Citation>Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML. Evaluation and treatment of adult growth hormone deficiency: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(6):1587&#x2013;609. doi: 10.1210/jc.2011-0179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2011-0179</ArticleId><ArticleId IdType="pubmed">21602453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lando A, Holm K, Nysom K, Rasmussen AK, Feldt-Rasmussen U, Petersen JH, et al. Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation. Clin Endocrinol (Oxf) 2001;55(1):21&#x2013;5. doi: 10.1046/j.1365-2265.2001.01292.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2265.2001.01292.x</ArticleId><ArticleId IdType="pubmed">11453948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Abe O, Saito T, et al. Successful pregnancy and delivery after Radiation with Ovarian shielding for Acute lymphocytic leukemia before Menarche. J Pediatr Hematol Oncol. 2015;37(5):e292&#x2013;294. doi: 10.1097/MPH.0000000000000309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPH.0000000000000309</ArticleId><ArticleId IdType="pmc">PMC4472319</ArticleId><ArticleId IdType="pubmed">25739028</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisi N, Iravani P, Raeissi P, Kelishadi R. Vitamin D and bone Minerals Status in the long-term survivors of Childhood Acute Lymphoblastic Leukemia. Int J Prev Med. 2015;6:87. doi: 10.4103/2008-7802.164691.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2008-7802.164691</ArticleId><ArticleId IdType="pmc">PMC4587070</ArticleId><ArticleId IdType="pubmed">26445634</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostoufi-Moab S, Brodsky J, Isaacoff EJ, Tsampalieros A, Ginsberg JP, Zemel B, et al. Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation. J Clin Endocrinol Metab. 2012;97(10):3584&#x2013;92. doi: 10.1210/jc.2012-2393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2012-2393</ArticleId><ArticleId IdType="pmc">PMC3674298</ArticleId><ArticleId IdType="pubmed">22865901</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson TM, Ehrhardt MJ, Ness KK. Obesity and metabolic syndrome among adult survivors of Childhood Leukemia. Curr Treat Options Oncol. 2016;17(4):17. doi: 10.1007/s11864-016-0393-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11864-016-0393-5</ArticleId><ArticleId IdType="pmc">PMC4813812</ArticleId><ArticleId IdType="pubmed">26951206</ArticleId></ArticleIdList></Reference><Reference><Citation>Razzouk BI, Rose SR, Hongeng S, Wallace D, Smeltzer MP, Zacher M, et al. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma. J Clin Oncol. 2007;25(10):1183&#x2013;9. doi: 10.1200/JCO.2006.07.8709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2006.07.8709</ArticleId><ArticleId IdType="pubmed">17401007</ArticleId></ArticleIdList></Reference><Reference><Citation>Hata M, Ogino I, Aida N, Saito K, Omura M, Kigasawa H, et al. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors. Int J Cancer. 2001;96:117&#x2013;24. doi: 10.1002/ijc.10348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.10348</ArticleId><ArticleId IdType="pubmed">11992395</ArticleId></ArticleIdList></Reference><Reference><Citation>Elitzur S, Houri-Shtrecher R, Yackobovitz-Gavan M, Avrahami G, Barzilai S, Gilad G, et al. Growth and pubertal patterns in young survivors of childhood acute lymphoblastic leukemia. J Pediatr Endocrinol Metab. 2017;30(8):869&#x2013;77. doi: 10.1515/jpem-2017-0099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jpem-2017-0099</ArticleId><ArticleId IdType="pubmed">28742520</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayram C, Yaral&#x131; N, Fettah A, Demirel F, Tavil B, Kara A, et al. Evaluation of endocrine late complications in Childhood Acute Lymphoblastic Leukemia Survivors: a report of a single-center experience and review of the literature. Turk J Haematol. 2017;34(1):40&#x2013;5. doi: 10.4274/tjh.2015.0332.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/tjh.2015.0332</ArticleId><ArticleId IdType="pmc">PMC5451687</ArticleId><ArticleId IdType="pubmed">27094350</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffens M, Beauloye V, Brichard B, Robert A, Alexopoulou O, Vermylen C, et al. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-hodgkin lymphoma (NHL) Clin Endocrinol (Oxf) 2008;69(5):819&#x2013;27. doi: 10.1111/j.1365-2265.2008.03283.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2008.03283.x</ArticleId><ArticleId IdType="pubmed">18429947</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves CH, Kuperman H, Dichtchekenian V, Damiani D, Della Manna T, Crist&#xf3;fani LM, et al. Growth and puberty after treatment for acute lymphoblastic leukemia. Rev Hosp Clin Fac Med Sao Paulo. 2004;59(2):67&#x2013;70. doi: 10.1590/S0041-87812004000200004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0041-87812004000200004</ArticleId><ArticleId IdType="pubmed">15122420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghassemi A, Banihashem A, Ghaemi N, Elmi S, Erfani Sayyar R, Elmi S, et al. Evaluation of bone Mineral density in children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin&#x2019;s Lymphoma (NHL): chemotherapy with/without Radiotherapy. Int J Hematol Oncol Stem Cell Res. 2016;10(3):153&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4969560</ArticleId><ArticleId IdType="pubmed">27489591</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilela MI, Serravite Mde O, Oliveira NB, de Brito PC, Ribeiro-Oliveira A, Jr, Viana MB. Height deficit and impairment of the GH/IGF-1 axis in patients treated for acute lymphoblastic leukemia during childhood. Horm Res Paediatr. 2013;79(1):9&#x2013;16. doi: 10.1159/000343936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000343936</ArticleId><ArticleId IdType="pubmed">23306635</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow EJ, Liu W, Srivastava K, Leisenring WM, Hayashi RJ, Sklar CA, et al. Differential effects of radiotherapy on growth and endocrine function among acute leukemia survivors: a childhood cancer survivor study report. Pediatr Blood Cancer. 2013;60(1):110&#x2013;5. doi: 10.1002/pbc.24198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.24198</ArticleId><ArticleId IdType="pmc">PMC3436954</ArticleId><ArticleId IdType="pubmed">22628201</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczuk-Rybak M, P&#x142;onowski M, Leszczy&#x144;ska E, Latoch E, Sawicka-&#x17b;ukowska M, Muszy&#x144;ska-Ros&#x142;an K, et al. The influence of different intensity of treatment on hormonal markers of gonadal function in acute lymphoblastic leukemia survivors. Hematol Oncol. 2019;37(5):609&#x2013;16. doi: 10.1002/hon.2681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hon.2681</ArticleId><ArticleId IdType="pubmed">31523837</ArticleId></ArticleIdList></Reference><Reference><Citation>Piette C, Suciu S, Bertrand Y, Uyttebroeck A, Vandecruys E, Plat G, et al. Long-term outcome evaluation of medium/high risk acute lymphoblastic leukaemia children treated with or without cranial radiotherapy in the EORTC 58832 randomized study. Br J Haematol. 2020;189(2):351&#x2013;62. doi: 10.1111/bjh.16337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16337</ArticleId><ArticleId IdType="pubmed">31837008</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicognani A, Cacciari E, Carl&#xe1; G, Rosito P, Cau M, Mancini AF, et al. Magnetic resonance imaging of the pituitary area in children treated for acute lymphoblastic leukemia with low-dose (18-Gy) cranial irradiation. Relationships to growth and growth hormone secretion. Am J Dis Child. 1992;146(11):1343&#x2013;8. doi: 10.1001/archpedi.1992.02160230101028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.1992.02160230101028</ArticleId><ArticleId IdType="pubmed">1415076</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimazaki S, Kazukawa I, Mori K, Kihara M, Minagawa M. Factors predicting endocrine late effects in childhood cancer survivors from a japanese hospital. Endocr J. 2020;67(2):131&#x2013;40. doi: 10.1507/endocrj.EJ19-0228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ19-0228</ArticleId><ArticleId IdType="pubmed">31656261</ArticleId></ArticleIdList></Reference><Reference><Citation>Adan L, Trivin C, Sainte-Rose C, Zucker JM, Hartmann O, Brauner R. GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults. J Clin Endocrinol Metab. 2001;86(11):5245&#x2013;51. doi: 10.1210/jcem.86.11.8056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.86.11.8056</ArticleId><ArticleId IdType="pubmed">11701685</ArticleId></ArticleIdList></Reference><Reference><Citation>Costin G. Effects of low-dose cranial radiation on growth hormone secretory dynamics and hypothalamic-pituitary function. Am J Dis Child. 1988;142(8):847&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">3164978</ArticleId></ArticleIdList></Reference><Reference><Citation>Siimes MA, Lie SO, Andersen O, Marky I, Rautonen J, Hertz H. Prophylactic cranial irradiation increases the risk of testicular damage in adult males surviving ALL in childhood. Med Pediatr Oncol. 1993;21(2):117&#x2013;21. doi: 10.1002/mpo.2950210207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mpo.2950210207</ArticleId><ArticleId IdType="pubmed">8433677</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana MB, Vilela MI. Height deficit during and many years after treatment for acute lymphoblastic leukemia in children: a review. Pediatr Blood Cancer. 2008;50(2 Suppl):509&#x2013;16. doi: 10.1002/pbc.21396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.21396</ArticleId><ArticleId IdType="pubmed">18064646</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung W, Rose SR, Zhou Y, Hancock ML, Burstein S, Schriock EA, et al. Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2002;20(13):2959&#x2013;64. doi: 10.1200/JCO.2002.09.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2002.09.142</ArticleId><ArticleId IdType="pubmed">12089225</ArticleId></ArticleIdList></Reference><Reference><Citation>Follin C, Thil&#xe9;n U, Ahr&#xe9;n B, Erfurth EM. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2006;91(5):1872&#x2013;5. doi: 10.1210/jc.2005-2298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2005-2298</ArticleId><ArticleId IdType="pubmed">16522695</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimis G, Moschovi M, Papassotiriou I, Chrousos G, Tzortzatou-Stathopoulou F. Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J Pediatr Hematol Oncol. 2007;29(5):309&#x2013;14. doi: 10.1097/MPH.0b013e318059c249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPH.0b013e318059c249</ArticleId><ArticleId IdType="pubmed">17483708</ArticleId></ArticleIdList></Reference><Reference><Citation>Orgel E, Sea JL, Mittelman SD. Mechanisms by which obesity impacts survival from Acute Lymphoblastic Leukemia. J Natl Cancer Inst Monogr. 2019;2019(54):152&#x2013;6. doi: 10.1093/jncimonographs/lgz020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jncimonographs/lgz020</ArticleId><ArticleId IdType="pmc">PMC6750167</ArticleId><ArticleId IdType="pubmed">31532535</ArticleId></ArticleIdList></Reference><Reference><Citation>Iughetti L, Bruzzi P, Predieri B, Paolucci P. Obesity in patients with acute lymphoblastic leukemia in childhood. Ital J Pediatr. 2012;38:4. doi: 10.1186/1824-7288-38-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1824-7288-38-4</ArticleId><ArticleId IdType="pmc">PMC3295712</ArticleId><ArticleId IdType="pubmed">22284631</ArticleId></ArticleIdList></Reference><Reference><Citation>Orgel E, Framson C, Buxton R, Kim J, Li G, Tucci J, et al. Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial. Blood Adv. 2021;5(7):1853&#x2013;61. doi: 10.1182/bloodadvances.2020004018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020004018</ArticleId><ArticleId IdType="pmc">PMC8045487</ArticleId><ArticleId IdType="pubmed">33792627</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffner PK. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors. Neurologist. 2004;10(6):293&#x2013;310. doi: 10.1097/01.nrl.0000144287.35993.96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.nrl.0000144287.35993.96</ArticleId><ArticleId IdType="pubmed">15518596</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>